Osalia

Osalia is a veterinary pharmaceutical laboratory dedicated to animal health. The company specializes in producing generic medications for various animal species, covering the main therapeutic classes and addressing the most common treatment needs. Osalia's generic drugs are manufactured in Europe, adhering to Good Manufacturing Practice standards set by French and European health authorities. The company focuses on providing quality, accessibility, and simplicity in its product offerings. Osalia's generic medications aim to reduce treatment costs, making them more accessible and improving adherence to veterinary prescriptions. In addition to pharmaceuticals, Osalia offers nutritional supplements such as NutriBoost Pet, a complementary food product designed to provide energy for newborn puppies and kittens during their first days of life. This product is particularly recommended for large litters, cesarean births, long labor, hypothermia, or absence of sucking reflex. NutriBoost Pet contains easily metabolizable energy sources, prebiotics and probiotics to strengthen the intestinal barrier, and vitamins to support cognitive function.

Key customers and partnerships

Osalia's customers primarily include independent veterinarians and those affiliated with Economic Interest Groups (GIEs). The company has implemented an environmental initiative in partnership with EcoTree, pledging to plant one tree for each of these veterinary clients. As of March 2023, Osalia had already financed 600 trees in the Langonnet forest in Morbihan, France, which is sustainably managed by EcoTree. The company aims to plant between 800 and 1,000 trees annually on behalf of its clients. This initiative allows Osalia's customers to become engaged actors in environmental protection efforts.